Anti-Human CD223 Recombinant Antibody(Relatlimab)

Name: Anti-Human CD223 Recombinant Antibody(Relatlimab)
Brand: KMD Bioscience
SKU: YR1487

YR1487

科研级 Relatlimab ( 瑞拉利单抗 ), Anti-CD223 Recombinant Antibody, Research Grade Relatlimab

DATASHEET MSDS

Product Description

Alias	科研级 Relatlimab ( 瑞拉利单抗 ), Anti-CD223 Recombinant Antibody, Research Grade Relatlimab
Catalog Number	YR1487
Molecular Name	Relatlimab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Relatlimab (INN, development code BMS-986016) is a monoclonal antibody designed for the treatment of melanoma. This drug is being developed by Bristol-Myers Squibb. As of 2018, relatlimab is undergoing Phase II/III trials.
CAS Number	1673516-98-7
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD223[Homo sapiens]

Login